glp-1 receptor agonists benefits for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes The expanding benefits of GLP-1

A retrospective analysis of safety in participants treated with a hybrid hyaluronic acid and calcium hydroxyapatite filler

1999;104:R33R39

Investigations conducted at 2023 have shown that vitamin D may also increase GLP-1 levels through the improvement of a healthy gut microbiome

Both drugs carry warnings in patients with a history of medullary thyroid carcinoma or MEN2 syndrome

In a study published in May, researchers used a large patient dataset to compare the NAION rate within 1 year of adults with Type 2 diabetes starting GLP-1 treatment (like Ozempic) versus those starting dipeptidyl peptidase 4 inhibitors

The breadth reflects Eli Lilly's strategy of establishing retatrutide not just as a weight-loss drug but as a cardiometabolic platform